85.93 USD
↘ 3.62 (4.04%)LIVE (AS OF 11:30 AM EST)
Dianthus Therapeutics, Inc. Common Stock (DNTH) trades at $85.93 per share. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Nov 16, 2026.